Flow Cytometer Reagents Market information: by type (calibration and validation reagents, specificity reagents, supporting reagents, secondary reagents, isotype controls, buffers), applications (diagnostics, drug discovery) end users (pharmaceutical and biotechnology industry, academic and research centers, diagnostic centers) - forecast till 2030

Flow Cytometer Reagents Market Overview

The flow cytometer reagents market is expected to gain a market value of USD 5,872.1 million by 2030 at a CAGR of 9.20 % from 2022-2030.

Flow cytometry is a technique used to measure and detect the physical and chemical characteristics of a population of particles or cells. It is used to characterize and define different types of cells in a heterogeneous cell population and facilitates evaluating the purity of isolated subpopulations.

The growth of the flow cytometer reagents market is primarily driven by the increasing prevalence of HIV/AIDS and cancer, the rising adoption of flow cytometry techniques in research activities, growing public-private initiatives in immunology and immuno-oncology research, and increasing technological advancements in flow cytometry software. According to World Cancer Research Fund International (WCRF) data, approximately 18 million cancer cases were recorded in 2018 globally. Out of these, almost 17,036,901 new cases were diagnosed in that year. A similar source reported around 437,033 newly diagnosed leukemia cases in 2018. Flow cytometry helps diagnose and arrange leukemia and distinguish between myeloid leukemia and lymphoid.

COVID-19 Analysis

The COVID-19 pandemic had a positive impact on the global flow cytometry market. The advancements in the flow cytometry technology or the introduction of new flow cytometry equipment have contributed to the COVID-19 research with its ability to conduct immunophenotyping that allows the identification of SARS-CoV-2-specific immune responses. The growing patient population is expected to drive the demand for flow cytometry instrument productions.

Flow Cytometer Reagents Market Dynamic

• Drivers

Factors- such as technological advancements in flow cytometers, increasing adoption of flow cytometry techniques in research activities and clinical trials, increasing focus on immunology and immuno-oncology research, increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software and the high incidence and prevalence of AIDS are driving flow cytometer reagent industry growth.

• Opportunities

Growing flow cytometer reagents market penetration in emerging nations, advancements in stem cell research, the use of recombinant DNA technology for antibody manufacturing, and the evolution of tandem flow cytometry technologies are projected to provide market participants with a wide variety of potential opportunities.

• Restraints

The high cost of flow cytometer reagents due to the proprietary nature of most reagents and the lack of market openness are flow cytometer reagents market restraints.

• Challenges

End-user purchasing power is anticipated to be limited, and product costs will be high, creating challenges for the market's leading important players and, consequently, impeding the expansion of the flow cytometer reagents market during the projection period.

Cumulative Growth Analysis

The entire flow cytometer reagents market is led by cell-based flow cytometry technology, which is expected to retain its dominance during the projected period. The growing need for early diagnosis and increased awareness of the benefits of cell-based flow cytometry are factors leading to its dominance. Furthermore, technology has several applications in a wide range of study fields. The physiological relevance of the data is what drives the use of cell-based flow cytometry technologies in drug development.

The reagents & consumables category has the largest market share in the goods & services industry. This is owing to the high penetration, as well as the perks such as exact results and user-friendliness. Furthermore, the advent of new technologies and their detecting capabilities increases demand for the products and services.

Value Chain Analysis

According to the reports, The worldwide flow cytometer reagents market has been classified into kinds, applications, end-users, and regions. The market has been divided into categories, which include calibration and validation reagents, specificity reagents, supporting reagents, secondary reagents, isotype controls, buffers, and others. The market has been divided into applications such as diagnostics, drug discovery, and others. The market has been divided into four segments based on end-users: pharmaceutical and biotechnology sector, academic and research institutions, diagnostic centers, and others.Figure 1Global flow cytometer reagents market by end users, 2016 (% market share)

Flow Cytometer Reagents Market Segmentation Overview

The flow cytometer reagents market is segmented on the basis of kinds, applications, end-users, and regions. The global flow cytometer reagents market is expected to witness decent growth during the forecast period.

By Application

Based on the application, the flow cytometer reagents market is segmented into diagnostics, drug discovery, and others.

By end-users

Based on the propulsion types, the flow cytometer reagents market is segmented into the pharmaceutical and biotechnology sector, academic and research institutions, diagnostic centers, and others.

Flow Cytometer Reagents Market Regional Analysis

According to the reports, on the basis of region, the flow cytometer reagents market is divided into North America, Europe, Asia Pacific, Latin America, and the middle east, and Africa. Because of widespread drug usage and high healthcare spending, the Americas account for a sizable flow cytometer market share. Furthermore, the rapid adoption of new technologies in the United States propels the worldwide flow cytometer reagents market. Furthermore, the concentration of large research organizations and the biotechnology industry in this region's developed countries are fueling the flow cytometer reagents market. Due to its strong industrial and scientific basis, Europe is the world's second-biggest flow cytometer reagents market share. During the projected period, the Asia Pacific region is predicted to develop significantly, with China and India likely to dominate this market due to their rapidly increasing industrial sectors. The Middle East and African markets are driven by Gulf states such as Saudi Arabia and the United Arab Emirates. Due to poor economic and political situations, as well as inadequate healthcare development, the African area is anticipated to expand at a modest pace.

North America dominates the flow cytometer reagents market due to the presence of supportive government reforms for the development of advanced technologies for molecular diagnostics, as well as the presence of a large number of clinical research labs and major pharmaceuticals in the United States, whereas Asia-Pacific is expected to grow at the fastest rate during the forecast period of 2022-2030 due to supportive government reforms.

Competitive landscape

A careful examination of the flow cytometer reagents market indicates that product creation is the most appealing technique, which has been used by many industry participants. The strong profit margins and returns on investment inflow cytometer reagents have resulted in market expansion, with several big corporations entering the flow cytometer company.

Major Key Players

• Biocompare, Bio-Rad Laboratories, Inc.


• Miltenyi Biotec


• BioLegend, Inc.


• Becton


• Dickinson and Company


• Beckman Coulter, Inc.


• Merck KGaA


• ImmunoReagents, Inc.


• Thermo Fisher Scientific


• others.

Flow Cytometer Reagents Market Report Overview

The following report comprises of –

• Market overview


• Covid 19 Analysis


• Market Dynamic


• Drivers


• Opportunities


• Restraints


• Challenges


• Cumulative Growth Analysis


• Value Chain Analysis


• Segmentation Overview


• By Application


• By End-Users


• Regional Analysis


• Competitive landscape

Recent Developments

• In March 2022, Beckman Coulter (a Danaher Corporation company) (US) announced launching CellMek SPS, aiming to automate the sample preparation system for clinical flow cytometry fully.


• September 2021, The California Institute for Regenerative Medicine (US) presented USD 31 million to three Stanford University (US) researchers to launch first-in-human trials of stem cells for heart failure, stroke treatment, and a type of brain and spinal cord tumor.

By Technology

• Cell-based Flow Cytometry


• Bead-based Flow Cytometry

By Product and Service

• Reagents and Consumables


• 
  Instruments
  
  
  
  • 
    Cell Analyzers
    
    
    
    • High-range
    
    
    • Mid-range
    
    
    • Low-range
    
    
    
    
  
  
  • 
    Cell Sorters
    
    
    
    • High-range
    
    
    • Mid-range
    
    
    • Low-range
    
    
    
    
  
  
  • Services
  
  
  • Software
  
  
  • Accessories
  
  
  
  

By Application

• 
  Research Applications
  
  
  
  • 
    Pharmaceuticals and Biotechnology
    
    
    
    • Drug Discovery
    
    
    • Stem Cell Research
    
    
    • In Vitro Toxicity Testing
    
    
    
    
  
  
  • Immunology
  
  
  • Cell Sorting
  
  
  • Apoptosis
  
  
  • Cell Cycle Analysis
  
  
  • Cell Viability
  
  
  • Cell Counting
  
  
  • Other Research Applications
  
  
  
  


• 
  Clinical Applications
  
  
  
  • Cancer Diagnostics
  
  
  • Hematology
  
  
  • Immunodeficiency Diseases
  
  
  • Organ Transplantation
  
  
  • Other Clinical Applications
  
  
  
  


• Industrial Applications

By End-User

• Academic & Research Institutes


• Hospitals & Clinical Testing Laboratories


• Pharmaceutical & Biotechnology Companies

By Region

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • UK
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe (RoE)
  
  
  
  


• 
  Asia Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of the Asia Pacific (RoAPAC)
  
  
  
  


• 
  Latin America
  
  
  
  • Brazil
  
  
  • Mexico
  
  
  • Rest of Latin America (Rest of LATAM)
  
  
  
  


• The Middle East and Africa